Healthcare & Life Sciences
Re-Vana Therapeutics, Ltd
United Kingdomwww.businesswire.com/news/home/20200602005114/en/Re-Vana-Therapeutics-Raises-3.25-Million-Pre-Series-Financing
activeseries-a
series-a
Stage
2018
Founded
1
Investors
About
Re-Vana Therapeutics develops photo-crosslinked, biodegradable ocular drug delivery systems engineered to provide sustained release of therapeutic agents such as biologics, peptides, and small molecules for treating various ocular conditions, aiming to reduce the need for frequent intravitreal injections.
Explore Re-Vana Therapeutics, Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.